Clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 Clinical Trials

Delta Trials tracks 20 clinical trials for Clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 in its publicly accessible dataset. Among the listed trials, 9 open for participant enrollment and 2 trials have reached completion. This research is carried out at 635 clinical sites around the world. An additional 9 trials have active registrations outside the recruiting and completed categories. Since 2020, 3 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.